3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Dermatologic
1
Conditions
Sarcoma, Kaposi
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Basal Cell
1
Interventions
pembrolizumab
3
talimogene laherparepvec
1
spartalizumab
1
daromun
1
avelumab
1
Therapeutics
1
TTI-621
1
Radiation, Ionizing
1
Radiation
1
Proton Pump Inhibitors
1
Nivolumab
1
Mohs Surgery
1
Ipilimumab
1
Hydrocortisone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
daromun
×
Sarcoma
×
Clear all
NCT05329792
2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2
Unknown
70 enrolled